Cameron Turtle
Chief Business Officer, Eidos Therapeutics, Inc.
Companies
- Damora Therapeutics, Inc.Board member Mar 25, 2026 to now1
- Oruka Therapeutics, Inc.Board member Sep 6, 2024 to now2
- Aeglea BioTherapeuticsBoard member Nov 27, 2023 to now3
- Aeglea BioTherapeuticsChief executive officer Nov 27, 2023 to now3
- Aeglea BioTherapeuticsChief Operating Officer Jun 30, 2023 to Jun 30, 20234
- BridgeBioOfficer Jun 27, 2019 to Dec 29, 20205
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aeglea BioTherapeutics SYRE552,540 shares6$43.8M at $79.33Sep 1, 2026
- Oruka Therapeutics, Inc. ORKA85,233 shares7$6.3M at $73.87Sep 6, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 1, 2026Sold 400 shares at $89.07 of Aeglea BioTherapeutics6
- Sep 1, 2026Sold 3,700 shares at $88.06 of Aeglea BioTherapeutics6
- Sep 1, 2026Sold 8,400 shares at $87.15 of Aeglea BioTherapeutics6
- Sep 1, 2026Sold 2,500 shares at $86.36 of Aeglea BioTherapeutics6
- Aug 3, 2026Sold 16 shares at $97.46 of Aeglea BioTherapeutics8
- Aug 3, 2026Sold 1,392 shares at $96.82 of Aeglea BioTherapeutics8
- Aug 3, 2026Sold 5,635 shares at $95.93 of Aeglea BioTherapeutics8
- Aug 3, 2026Sold 7,157 shares at $95.10 of Aeglea BioTherapeutics8
- Aug 3, 2026Sold 800 shares at $93.97 of Aeglea BioTherapeutics8
- Jul 1, 2026Sold 590 shares at $88.91 of Aeglea BioTherapeutics9
- Jul 1, 2026Sold 4,234 shares at $88.12 of Aeglea BioTherapeutics9
- Jul 1, 2026Sold 10,176 shares at $87.44 of Aeglea BioTherapeutics9
- Jun 1, 2026Sold 3,294 shares at $71.38 of Aeglea BioTherapeutics10
- Jun 1, 2026Sold 8,149 shares at $70.50 of Aeglea BioTherapeutics10
- Jun 1, 2026Sold 3,557 shares at $69.40 of Aeglea BioTherapeutics10
- May 1, 2026Sold 300 shares at $74.96 of Aeglea BioTherapeutics11
- May 1, 2026Sold 1,700 shares at $74.23 of Aeglea BioTherapeutics11
- May 1, 2026Sold 3,100 shares at $73.14 of Aeglea BioTherapeutics11
- May 1, 2026Sold 1,000 shares at $71.76 of Aeglea BioTherapeutics11
- May 1, 2026Sold 3,600 shares at $70.77 of Aeglea BioTherapeutics11
- May 1, 2026Sold 5,300 shares at $69.54 of Aeglea BioTherapeutics11
- Apr 1, 2026Sold 2,656 shares at $49.92 of Aeglea BioTherapeutics12
- Apr 1, 2026Sold 12,344 shares at $49.20 of Aeglea BioTherapeutics12
- Mar 2, 2026Sold 9,100 shares at $42.49 of Aeglea BioTherapeutics13
- Mar 2, 2026Sold 5,900 shares at $41.73 of Aeglea BioTherapeutics13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARAeglea BioTherapeutics, Board member
- 4
- 5SEC EDGARBridgeBio, Officer
- 6
- 7
- 8SEC EDGARForm 4 filed Aug 5, 2026
- 9SEC EDGARForm 4 filed Jul 2, 2026
- 10SEC EDGARForm 4 filed Jun 3, 2026
- 11SEC EDGARForm 4 filed May 1, 2026
- 12SEC EDGARForm 4 filed Apr 3, 2026
- 13SEC EDGARForm 4 filed Mar 3, 2026